Profile picture

Doctor Mauro Gori

Papa Giovanni XXIII Hospital, Bergamo (Italy)
Membership: FESC Member
Follow
Biography
He has been working in the Cardiology Department of Papa Giovanni Hospital since 2005. In 2000, he graduated in Medicine and Surgery at University of Pavia with 110/110 and honors. In 2003, he attended as clinical fellow the University Hospital Gasthuisberg, Leuven, Belgium. In 2004 he specialized in Cardiology at the University of Brescia, Italy. In 2012/2013 he attended a post-doctoral research fellowship at the Cardiac Imaging Core Laboratory directed by Professor Solomon, Brigham and Women’s Hospital, Boston, USA. His main area of work has been heart failure. He is proficient in managing heart failure patients and associated comorbidities, and in echocardiographic techniques. He has special interest in advanced heart failure and in heart failure with preserved ejection fraction (HFpEF). He has conducted many research projects, in collaboration with national and international societies. He is contract professor at School of Medicine and Surgery, Bergamo, Milano.
Logo ESC

Contributor content

Association between calcium channel blockers prescription and outcome according to left ventricular ejection fraction: data from a real-world heart failure population
Presentation
Association between calcium channel blockers prescription and outcome according to left ventricular ejection fraction: data from a real-world heart failure population
Discharge medical treatment implementation in patients admitted for AHF: preliminary data from the BRING-UP3 HF study
Presentation
Discharge medical treatment implementation in patients admitted for AHF: preliminary data from the BRING-UP3 HF study
Prognostic stratification of acute heart failure patients using the 3C-HF SCORE: short vs long term prediction
Presentation
Prognostic stratification of acute heart failure patients using the 3C-HF SCORE: short vs long term prediction
Combined neuro-humoral modulation and outcome in patients with chronic heart failure and mildly reduced or preserved ejection fraction
Presentation
Combined neuro-humoral modulation and outcome in patients with chronic heart failure and mildly reduced or preserved ejection fraction
Prognostic role of Gait speed and neutrophil to lymphocyte ratio in advanced heart failure
Presentation
Prognostic role of Gait speed and neutrophil to lymphocyte ratio in advanced heart failure
Diastolic dysfunction is an independent predictor of adverse events in patients with systolic dysfunction. Insights from the MADIT-CRT trial
Presentation
Diastolic dysfunction is an independent predictor of adverse events in patients with systolic dysfunction. Insights from the MADIT-CRT trial
Prognostic relevance of preclinical diastolic dysfunction across left ventricular ejection fraction categories. The DAVID-Berg study
Presentation
Prognostic relevance of preclinical diastolic dysfunction across left ventricular ejection fraction categories. The DAVID-Berg study

ESC 365 is supported by